Acadian Asset Management LLC has recently announced that it has increased stake in HOOKIPA Pharma Inc. (NASDAQ:HOOK) by 6.02%. After grabbing 0.68 million shares, the institutional investor is now in possession of 38759.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.30% having worth around $0.68 million. Moreover, RBC Capital Markets LLC increased its share by 20924.0 to have a control over 0.42 million shares.
HOOKIPA Pharma Inc. (HOOK) concluded trading on 05/25/23 at a closing price of $1.29, with 0.9 million shares of worth about $1.16 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 29.00% during that period and on Thursday the price saw a loss of about -9.15%. Currently the company’s common shares owned by public are about 54.72M shares, out of which, 48.05M shares are available for trading.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 8 analysts are covering the HOOK stock and their offered price forecasts bring an average price target of $4.44. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $8.00 and could fall to a lowest price of $0.50. The stock’s current price level is 70.95% above of average price target set by the analysts, while a rise to estimated low would result in loss of -158.0% for the stock. However, touching the estimated high of $8.00 would mean a gain of 83.88% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Fidelity Select Port. – Biotechno, Vanguard Total Stock Market ETF, and Fidelity VIP – Growth Portfolio are the top 3 mutual funds which are holding stakes in HOOKIPA Pharma Inc. Fidelity Select Port. – Biotechno is currently holding 1.48 million shares of worth totaling $1.48 million. The company recently came buying 0.0 shares which brought its stake up to 2.83% of the company’s outstanding shares. Fidelity VIP – Growth Portfolio, after buying 1.19 million shares, have now control over 2.27% of the stake in the company. It holds 0.0 shares of worth $1.19 million.
HOOKIPA Pharma Inc. (NASDAQ: HOOK) started trading at $1.41, below -$0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 1.4299, or with a loss of -9.15%. Stock saw a price change of -4.44% in past 5 days and over the past one month there was a price change of 27.72%. Year-to-date (YTD), HOOK shares are showing a performance of 59.26% which decreased to -12.24% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.68 but also hit the highest price of $2.05 during that period. The average intraday trading volume for HOOKIPA Pharma Inc. shares is 843.68K. The stock is currently trading -13.06% below its 20-day simple moving average (SMA20), while that difference is up 21.87% for SMA50 and it goes to 15.46% higher than SMA200.
Acadian Asset Management LLC acquired 0.68 million shares of HOOKIPA Pharma Inc. having value of about $0.68 million. Data submitted at the U.S SEC by Acadian Asset Management LLC revealed that the firm now holds 38759.0 shares in the company valued at close to $49999.11, or have control over 6.02% stake in the company. HOOKIPA Pharma Inc. (NASDAQ: HOOK) currently have 54.72M outstanding shares and institutions hold larger chunk of about 62.90% of that. Holding of mutual funds in the company is about 14.43% while other institutional holders and individual stake holders have control over 28.17% and 14.22% of the stake respectively.
The stock has a current market capitalization of $69.08M and its 3Y-monthly beta is at 0.77. It has posted earnings per share of -$1.18 in the same period. It has Quick Ratio of 3.20 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HOOK, volatility over the week remained 11.43% while standing at 15.93% over the month.
Analysts are in expectations that HOOKIPA Pharma Inc. (HOOK) stock would likely to be making an EPS of -$0.25 in the current quarter, while forecast for next quarter EPS is -$0.24 and it is -$1.15 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.3 which is -$0.22 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.23 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 57.00% while it is estimated to decrease by -14.30% in next year. EPS is likely to grow at an annualized rate of 14.50% for next 5-years, compared to annual growth of -14.60% made by the stock over the past 5-years.
Analysts at 8 brokerage firms have issued recommendations for the HOOKIPA Pharma Inc. (HOOK)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.10. Out of those 8 Wall Street analysts, 6 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Leave a Reply